Patient Blood Management

Why Participate?

  • Reduce patient harm: Reform transfusion practice

  • Learn how Western Australia is a world exemplar in PBM

  • Share strategies to meet #7 of the National Standards

  • Reclaim excess beddays

  • Reduce Blood product costs


Select Roundtable SIG6 on your subscription agreement and return by email to


$A5,750* for first facility in your network. $A4,750* for each additional facility. *excl GST
Individual delegate venue fees are billed separately.

Improvement Group Name

Improving Patient Blood Management

1-2 August 2018 - Sydney
Meeting Code HRT1815

In partnership with leading clinical experts, this Special Interest Group (SIG) seeks to optimise care by better managing and preserving patients and blood and reducing the requirement for transfusion.

The Problem:
International consensus:
10% of blood transfusions are appropriate
40% have uncertain benefits
50% inappropriate
There is a large variation in transfusion practice among Roundtable members. For planned surgical and obstetric patients screening and remediating anaemia is the solution.

The Opportunity: Patient Blood Management is an important safety and quality initiative with the potential to improve patient outcomes whilst also reducing hospital expenditure.

  • Red Blood Cell (RBC) transfusion is independently associated with increased morbidity, mortality, hospital and ICU length of stay, and increased cost.
  • On average, RBC transfused patients stay 2.5 days longer, with increased odds ratio of death of 1.7.
  • A recent West Australian study estimated the total hospital-associated cost of RBC transfusion across a five hospital health service to be $77 million per year.
  • Australian NSQHS Standard 7 requires that hospitals have systems in place to ensure safe and appropriate prescribing and use of blood and blood products, and that they are consistent with national evidence-based guidelines.

The Solution: Can we afford NOT to do Patient Blood Management? Western Australia is a world exemplar in PBM, we can all implement workable solutions based on the WA strategies and experience.

The problem: Western Australia Metro Data on Transfusion and Cost Retrospective cohort study from a five hospital health service in Western Australia between (July 2011 - June 2012).

After adjusting for age, gender, admit type (emergency or elective), DRG and patient complexity (HRT complexity), compared with non-transfused:

  • Mean inpatient cost 1.83 Times higher in txed group.
  • Estimated total hospital associated cost of RBC transfusion AUD $77 million, representing 7.8% of total hospital expenditure on acute-care inpatients.
  • Significant dose-dependent association between the number of RBC units transfused and increased costs after adjusting for confounders.

Who should participate?
  • This Roundtable is intended to share "good practice" ideas and innovations for PBM programs.
  • Ideally, a cross-disciplinary team of those who are responsible for PBM.
  • You may bring up to five people per health service.
What does The Health Roundtable do?
  • Work with experts to identify key trends and innovations.
  • Survey participating health services for innovative practices.
  • Collate and analyse results.
  • Summarise the meeting and circulate all presentations.

Sydney Office

Suite 804
28 Foveaux Street
Surry Hills, NSW 2010

Call Us

In Australia: ‎+61 (02) 8041-1421‎

In New Zealand: +64 (09) 889 0332

© 1995-2019 The Health Roundtable   

Partners and Members